Public Summary Documents – March 2022 PBAC meeting

1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...

Read more →

ICER releases draft evidence report on treatments for amyotrophic lateral sclerosis

14 June 2022 - Public comment period now open until 13 July 2022; requests to make oral comment during public ...

Read more →

ICER publishes evidence report on gene therapy for beta thalassaemia

2 June 2022 - Evidence judged to demonstrate that beti-cel provides net health benefit to patients with transfusion-dependent thalassaemia. ...

Read more →

Where is the PHARMAC review?

28 May 2022 - “It has been three months to the day since the Minister received the PHARMAC review, why ...

Read more →

Calls for Health Minister to release final report from PHARMAC review

11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...

Read more →

Health economic assessment of Abecma in the treatment of multiple myeloma

6 May 2022 - TLV has produced a health economic assessment for the regions for Abecma (idecabtagene vicleucel).  ...

Read more →

Health economic assessment of Blenrep in the treatment of multiple myeloma

6 May 2022 - TLV has produced a health economic assessment for the regions for the drug Blenrep (belantamab mafodotin).  ...

Read more →

Public summary documents – December 2021 PBAC meeting (first time decisions not to recommend, deferrals and other matters)

14 April 2022 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the December ...

Read more →

ICER releases draft evidence report on gene therapy for beta thalassaemia

13 April 2022 - Public comment period now open until 10 May 2022; requests to make oral comment during public ...

Read more →

Life Saving Drugs Program – medicines reviews recommendations

7 April 2022 - This document outlines 51 recommendations from the Life Saving Drugs Expert Panel review. ...

Read more →

Public Summary Documents – December 2021 PBAC meeting

1 April 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2021 PBAC ...

Read more →

ACE releases latest trance of drug guidances (April 2022)

1 April 2022 - The Agency for Clinical Effectiveness has released another batch of drug guidances. ...

Read more →

ICER publishes evidence report on treatments for COVID-19

28 March 2022 - Current evidence suggests all four drugs under review have prices reasonably aligned with patient benefits. ...

Read more →

DUSC utilisation analysis public release documents

25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...

Read more →

Public summary documents – November 2021 PBAC meeting (first time rejections and deferrals)

18 March 2022 - The Public Summary Documents (first time rejections and deferrals) from the November 2021 PBAC meeting are now ...

Read more →